Ex vivo stone surgery in donor kidneys at renal transplantation
Objective To report our experience on the outcomes of ex vivo ureteroscopy and ex vivo pyelolithotomy carried out on the donor kidney before living donor renal transplantation. Methods Between 2009 and 2016, 13 stone‐bearing donor kidneys underwent ex vivo bench surgery after donor nephrectomy. Of t...
Saved in:
Published in | International journal of urology Vol. 25; no. 10; pp. 844 - 847 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Australia
Wiley Subscription Services, Inc
01.10.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective
To report our experience on the outcomes of ex vivo ureteroscopy and ex vivo pyelolithotomy carried out on the donor kidney before living donor renal transplantation.
Methods
Between 2009 and 2016, 13 stone‐bearing donor kidneys underwent ex vivo bench surgery after donor nephrectomy. Of these, six patients underwent ex vivo ureteroscopy and seven patients underwent ex vivo pyelolithotomy. Data were analyzed for technical feasibility, intraoperative and postoperative complications, stone clearance, and stone recurrence.
Results
The mean stone burden was 9.1 mm (range 5–15 mm). Renal collecting system access and stone extraction were successfully achieved, and a stone‐free status was accomplished with both techniques. The mean duration of ex vivo ureteroscopy was 12.5 min (range 9–20 min), and the mean duration of ex vivo pyelolithotomy was 3.1 min (range 1–8 min). One patient in the pyelolithotomy group developed urinary leakage and underwent surgical repair on the third postoperative day. The mean long‐term follow‐up duration was 49.6 months (range 14–101 months). None of the 13 patients included in the study suffered from stone recurrence.
Conclusions
Our experience suggests that both ex vivo ureteroscopy and ex vivo pyelolithotomy procedures can safely and effectively be carried out in stone‐bearing living donor kidneys, without compromising renal allograft function. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0919-8172 1442-2042 |
DOI: | 10.1111/iju.13755 |